Cell. 2025 Feb 20;188(4)(IF:66.850).
2025-02-20Cell. 2025 Feb 20;188(4):1119-1136.e23.doi: 10.1016/j.cell.2024.12.010. Epub 2025 Jan 17. Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients 癌症难治性患者超急性排斥反应工程溶瘤病毒介入临床试验 (IF:66.850).